Skip to main content
Fig. 4 | Thrombosis Journal

Fig. 4

From: Replacement of traditional prothrombin time monitoring with the new Fiix prothrombin time increases the efficacy of warfarin without increasing bleeding. A review article

Fig. 4

Cumulative non-fatal and fatal thromboembolic events (panel A) and major bleeding (panel B) during treatment days 1–720 of the randomized double blind Fiix trial in patients monitored either with Fiix-warfarin (blue) or PT-warfarin (red). Reproduced with permission from The Lancet Haematology 2015;2:e231-e40 [35].

Back to article page

Thrombosis Journal

ISSN: 1477-9560

Contact us